Lipocine Inc. Annual Return On Equity in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lipocine Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2023.
  • Lipocine Inc. Return On Equity for the quarter ending September 30, 2024 was -19.2 %, a 65.1% increase year-over-year.
  • Lipocine Inc. annual Return On Equity for 2023 was -63.3 %, a 129% decline from 2022.
  • Lipocine Inc. annual Return On Equity for 2022 was -27.7 %, a 1606% decline from 2021.
  • Lipocine Inc. annual Return On Equity for 2021 was -1.62 %, a 99% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -63.3 -35.6 -129% Jan 1, 2023 Dec 31, 2023
2022 -27.7 -26 -1606% Jan 1, 2022 Dec 31, 2022
2021 -1.62 +168 +99% Jan 1, 2021 Dec 31, 2021
2020 -169 -25.7 -17.9% Jan 1, 2020 Dec 31, 2020
2019 -144 -53.6 -59.5% Jan 1, 2019 Dec 31, 2019
2018 -90.1 +0.34 +0.38% Jan 1, 2018 Dec 31, 2018
2017 -90.5 -27.5 -43.7% Jan 1, 2017 Dec 31, 2017
2016 -63 -18.6 -41.8% Jan 1, 2016 Dec 31, 2016
2015 -44.4 +17.9 +28.8% Jan 1, 2015 Dec 31, 2015
2014 -62.3 -9.6 -18.2% Jan 1, 2014 Dec 31, 2014
2013 -52.7 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.